Cargando…
Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis
OBJECTIVE: To undertake a systematic review and meta-analysis examining the impact of polypharmacy on health outcomes in atrial fibrillation (AF). DATA SOURCES: PubMed and Embase databases were searched from inception until 31 July 2019. Studies including post hoc analyses of prospective randomised...
Autores principales: | Gallagher, Celine, Nyfort-Hansen, Karin, Rowett, Debra, Wong, Christopher X, Middeldorp, Melissa E, Mahajan, Rajiv, Lau, Dennis H, Sanders, Prashanthan, Hendriks, Jeroen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254112/ https://www.ncbi.nlm.nih.gov/pubmed/32509316 http://dx.doi.org/10.1136/openhrt-2020-001257 |
Ejemplares similares
-
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023) -
Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation
por: Jackson, Adam, et al.
Publicado: (2021) -
Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation
por: Parwani, Abdul Shokor, et al.
Publicado: (2017) -
Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018) -
High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)